Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
242.50    7.50 (3.19%)
Bid:
240.00
Ask:
245.00
Spread: 5.00 (2.083%)
Market Cap: £87.20m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Interim Management Statement

28 Oct 2010 07:00

RNS Number : 1334V
Alumasc Group PLC
28 October 2010
 



Thursday 28 October 2010

 

THE ALUMASC GROUP PLC - INTERIM MANAGEMENT STATEMENT

 

 

Alumasc, the premium building and engineering products company, is publishing its first interim management statement for the year ending 30 June 2011 ahead of its Annual General Meeting being held in London at 10.30am today.

 

Overall trading for the year to date has been in line with the Board's expectations, with group revenues more than 10% ahead of prior year levels.

 

First quarter revenues within the Building Products division were similar to the first quarter of the prior year and, encouragingly, have now risen for the last two quarters in succession, despite uncertainty over the potential impact of the UK government's Comprehensive Spending Review.

Alumasc Precision, the group's largest Engineering Products business, has continued to benefit from the strongly positive trading momentum begun early in the second half of the last financial year. Underlying demand across the customer base has continued to grow and, in addition, a significant new project was won recently to supply components for a complex transmission system to Caterpillar.

 

Net debt at 30 September 2010 was £10.9 million, £1.6 million higher than at the last year end due to anticipated increases in working capital requirements as revenues have grown. Group borrowings remain comfortably within committed financing facilities of £20 million.

 

There have been no other significant changes to the group's balance sheet since 30 June 2010, and there have been no significant non-recurring items impacting the income statement for the current financial year.

 

The group's order book currently totals over £40 million, around 20% ahead of prior year end levels and over 50% ahead of the low point in December 2009, with the majority of the uplift at Alumasc Precision.

 

In view of positive year to date trading and growth in the order book, with an increasing proportion of group profit being generated by the Engineering Products division, the Board continues to believe that Alumasc is well positioned to make progress through uncertain times and achieve its expectations for current year financial performance.

 

END

 

Enquiries:

 

The Alumasc Group plc

Paul Hooper (Group Chief Executive) Tel: 01536 383821

Andrew Magson (Group Finance Director) Tel: 01536 383844

 

Bankside Consultants

Simon Bloomfield Tel: 0207 367 8861

Rose Oddy Tel: 0207 367 8853

 

 

 

 

This Interim Management Statement has been drawn up and presented for the purposes of complying with English law. Any liability arising out of or in connection with this Interim Management Statement will also be determined in accordance with English law.

 

This Interim Management Statement may contain 'forward-looking statements'. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Many of these risks and uncertainties relate to factors beyond The Alumasc Group's control or which cannot be estimated precisely, such as future market conditions and the behaviour of the market participants. Actual outcomes and results may therefore differ materially from any outcomes or results expressed or implied by any such forward-looking statements.

 

Nothing in this Interim Management Statement is intended to be a profit forecast.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFDLLLBBFEFBE
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.